Medical Cannabis Research Australia

About Us

Who we are

Medical Cannabis Research Australia was established in December 2016 by Paul & Sharlene Mavor and Tony Hume.  Jason Jordan joined the Board in October 2018.  Suresh Rajan joined the Board in December 2019.

Sharlene Mavor is a medical scientist with majors in Microbiology, Virology and Biotechnology. She has worked in a number of laboratories both in Western Australia and in the UK. Sharlene has a particular interest in different cannabis strains, potency and purity testing and extraction methods.

Jason Jordan is an experienced company director having been on the board of both corporate and not-for-profit organisations.  He has also been involved in the Media Industry since 1989.  Jason has Multiple Sclerosis and is currently receiving Medical Cannabis.

Suresh Rajan brings a wealth of capability, skill and knowledge to the Board.  Suresh is well-known in Perth for his advocacy on many social issues and his passionate, long-term participation in the Not-For-Profit Sector.  Suresh was previously CEO of Epilepsy WA and understands the power of Medical Cannabis.

Our Leadership Team

Managing Director &
Research Director

Sharlene Mavor

Chairman &
Media Director

Jason jordan

Charity Director

Suresh Rajan

Medical Cannabis Research Australia is committed to improve the lives of Australians and their families by reducing the suffering, prevalence and impact of a variety of diseases through the use of medical cannabis.

This will be achieved with a focus on clinical trials and ethical supply of medical cannabis.

Research will be conducted to support and promote public awareness for the use of medical cannabis including education for clinical practitioners with new treatment options, both locally and globally for their patients.

We aim to educate and advise health professionals, patients, their families and carers in the use of medical cannabis through media, education and fund raising campaigns and further cooperate with government and likeminded organisations in order to advance the research, treatments, equity and quality of life which can be assisted with the use of medical cannabis.

Menu